HMGB2 up-expression suggested both worse OS and RFS of ACC, KIRP, LGG, and LIHC; worse OS of MESO and PAAD; worse RFS of LUAD and PRAD; and better OS of SKCM. The gene discussed is HMGB2; the disease is prostate adenocarcinoma.